Neomycin sulfate

73 Cited Publications
Avis client

Based on 73 publication(s) in Google Scholar

Neomycin sulfate, an aminoglycoside antibiotic, exerts antibacterial activity through irreversible binding of the nuclear 30S ribosomal subunit, thereby blocking bacterial protein synthesis. Neomycin sulfate is a known phospholipase C (PLC) inhibitor. Neomycin sulfate potently inhibits both the nuclear translocation of angiogenin and angiogenin-induced cell proliferation and angiogenesis. Neomycin sulfate inhibits IP3-mediated Ca2+ release, MgATP-dependent Ca2+ uptake, and electrical excitation-evoked skeletal muscle Ca2+ transients. Neomycin sulfate depletes gut microbiota in specific mouse models, causes hearing impairment, and kidney damage with prolonged exposure. Neomycin sulfate can be used for the research of cancer.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 99.86%
  • CAS No.: 1405-10-3
  • Formule: C23H52N6O25S3
  • Masse moléculaire:908.88
  • Stockage:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Activité biologique
  • Chemical Information
  • Solvant et solubilité
  • Pureté et documentation
  • Références
  • Help & FAQs
You May Still Need

Publications Citing Use of MedChemExpress (MCE) Neomycin sulfate

More
Customer Validation & Images
In Vivo Efficacy StudyPK/PD AnalysisOthersBio/Physico-chemical Assay
  • In Vivo Efficacy Study
  • Others
  • PK/PD Analysis
  • Bio/Physico-chemical Assay

Voir tous les produits spécifiques à Isoform Phospholipase

More

Voir tous les produits spécifiques à Isoform Antibiotic

More
100 mg

Obtenir un devis En stock

Please select quantity
Amount: USD 0.00